FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...

HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine.

Q1 2025 net revenue of $20.4 million, driven by product net revenue of $17.2 million Completed sale of PRV for gross proceeds of $150 milli ...

Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of ...

Strong execution and progress across pipeline with multiple key data read outs expected in 2025Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in JunePhase 3 barzolvolimab CSU ...

Researchers conducted a cross-sectional study at six tertiary photobiology units in the United Kingdom between October 2019 ...

Jasper Therapeutics, Inc.’s JSPR share price has dipped by 5.34%, which has investors questioning if this is right time to ...

Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab experienced ...

Delayed Pressure Urticaria (DPU) is a rare form of Chronic Inducible Urticaria (CIndUs) defined by the appearance of a skin swelling response after the application of a sustained pressure stimulus to ...

CHRONIC spontaneous urticaria (CSU) is a distressing inflammatory skin condition characterised by the recurrent appearance of hives, angioedema, or both, lasting more than six weeks without an ...

A longitudinal cohort study of older veterans found that a history of military sexual trauma (MST) is associated with increased risk for any suicide attempt and death by drug overdose in both women ...